Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | PPID | Q08752 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CFD | P00746 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL714625 | 0.87 | EPHX1 (0.77) | SMN1; SMN2EPHX1TP53PTPN1EPHX2 | |
| SCHEMBL14365887 | 0.84 | AOC3 (0.63) | SMN1; SMN2EPHX2LMNACFDALDH1A1 | |
| SCHEMBL4188819 | 0.84 | SMN1; SMN2 (0.62) | SMN1; SMN2EPHX1TP53PTPN1EPHX2 | |
| SCHEMBL6033584 | 0.83 | TP53 (0.75) | SMN1; SMN2EPHX1TP53PTPN1EPHX2 | |
| SCHEMBL4424117 | 0.82 | KMT2A (0.68) | SMN1; SMN2EPHX2MEN1KMT2AHDAC1 | |
| SCHEMBL17864825 | 0.82 | HDAC6 (0.61) | TP53GAARAB9AKMT2ALMNA | |
| SCHEMBL17864831 | 0.82 | PADI3 (0.48) | SMN1; SMN2EPHX1PTPN1EPHX2MAPT | |
| SCHEMBL4486771 | 0.82 | KMT2A (0.66) | SMN1; SMN2EPHX1MAPTL3MBTL1GAA | |
| SCHEMBL14075472 | 0.82 | MEN1 (0.52) | SMN1; SMN2TP53PTPN1EPHX2NPC1 | |
| SCHEMBL970225 | 0.82 | SMN1; SMN2 (0.70) | SMN1; SMN2EPHX1TP53PTPN1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104780761-A | Use of substituted 2, 3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress | BAYER CROPSCIENCE AG | 2015-07-15 | — | — | CN | claimed |
| CN-101022810-A | Novel biaromatic compounds which activate peroxisome proliferator activated receptor-like receptors and their use in cosmetic or pharmaceutical compositions | GALDERMA RES & DEV (FR) | 2007-08-22 | — | — | CN | claimed |
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | claimed |
| EP-3675858-B1 | IMIDAZO[1,5-A]PYRAZINE COMPOUNDS AND COMPOSITIONS FOR IRE1 INHIBITION | OPTIKIRA LLC (US) | 2023-04-26 | — | — | EP | disclosed |
| US-20230076435-A1 | MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2023-03-09 | — | — | US | disclosed |
| WO-2021161230-A1 | SMALL MOLECULE STING ANTAGONISTS | CURADEV PHARMA PVT. LTD. (IN) | 2021-08-19 | — | — | WO | disclosed |
| US-20210238141-A1 | COMPOUND, CURING AGENT COMPOSITION, RESIN COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-08-05 | — | — | US | disclosed |
| EP-1887008-B1 | THIENOTRIAZOLODIAZEPINE COMPOUND AND A MEDICINAL USE THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2021-04-21 | — | — | EP | disclosed |
| EP-3319963-B1 | SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-01-08 | — | — | EP | disclosed |
| US-10351522-B2 | Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof | UNIVERSITY OF TSUKUBA (JP) | 2019-07-16 | — | — | US | disclosed |
| EP-2427451-B1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM BIOLAB CO LTD (JP) | 2019-03-20 | — | — | EP | disclosed |
| US-4621149-A | PLATINUM GROUP METAL HALOGEN OR HALOGEN COMPOUND | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1986-11-04 | — | — | US | disclosed |
| EP-0083096-A2 | Production of urethane compounds | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1983-07-06 | — | — | EP | disclosed |
| US-4332953-A | FOR PREPARING URETHANE FOAMS AND ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1982-06-01 | — | — | US | disclosed |
| US-4331809-A | INTERMEDIATES FOR PREPARING POLYURETHANE FOAMS AND ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |
| US-4331810-A | Carbamylbiuret-modified polyisocyanates | BASF WYANDOTTE CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |
| US-4330636-A | Carbamylbiuret-modified polyisocyanates | BASF WYANDOTTE CORPORATION (US) | 1982-05-18 | — | — | US | disclosed |
| US-4271087-A | WHICH CAN ALSO CONTAIN GUANIDINE LINKAGES AND THIOUREA LINKAGES | BASF WYANDOTTE CORPORATION (US) | 1981-06-02 | — | — | US | disclosed |
| US-4089860-A | Preparation of hydantoins by reacting esters of ethylene-1,2-dicarboxylic acids and ureas and thioureas | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-16 | — | — | US | disclosed |
| US-4056527-A | HERBICIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230076435-A1 | MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | GRM4, GRM5, GRIA4 | SMN1; SMN2 2186/4885EPHX1 1358/4885TP53 4861/4885 |
| US-10351522-B2 | Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof | HCRTR2, HCRTR1, NPSR1 | SMN1; SMN2 1062/4885EPHX1 2727/4885TP53 4884/4885 |
| US-20210238141-A1 | COMPOUND, CURING AGENT COMPOSITION, RESIN COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | CARM1, KDM2B, UFM1 | SMN1; SMN2 2519/4885EPHX1 3011/4885TP53 4499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.